Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China

Deng, WS; Hu, J; Li, MT; Yang, SS; Xie, ZY; Chen, JS

Chen, JS (通讯作者)，Guangdong Pharmaceut Univ, Affiliated Hosp 1, Key Specialty Clin Pharm, 19 Nonglinxia Rd, Guangzhou 510080, Guangdong, Peoples R China.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022; 22 (7): 1117

Abstract

Plain Language Summary Metastatic HER-2 positive breast cancer poses a considerable cost to society due to limitations in health care resources. HLX02......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索